Navigation Links
Simcere Pharmaceutical Group to Announce First Quarter 2011 Financial Results on Tuesday, May 10, 2011
Date:4/26/2011

NANJING, China, April 26, 2011 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2011 on Tuesday, May 10, 2011, before the market opens in the United States. Simcere's management will host an earnings conference call on the same day at 8 a.m. ET (Tuesday, May 10 at 8 p.m. Beijing/Hong Kong time).To access the conference call, please dial:United States toll-free:

+1.800.573.4840International:

+1.617.224.4326China Telecom:

10.800.120.2655/10.800.130.0399/10.800.152.1490China Netcom:

10.800.852.1490/10.800.712.2655China 400 (for mobile users)400.881.1630 / 400.881.1629Hong Kong:

+852.3002.1672Please ask to be connected to Q1 2011 Simcere Pharmaceutical Group Earnings Conference Call and provide the following passcode: 26446178.

Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's web site at www.simcere.com.

Following the earnings conference call, an archive of the call will be available by dialing:United States toll-free:+1.888.286.8010International:

+1.617.801.6888The passcode for replay participants is: 26589448.The telephone replay also will be archived on the "Investor Relations" section of the company's web site for seven days following the earnings announcement.

About Simcere Pharmaceutical GroupSimcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuti
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
2. Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
3. Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
4. Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production
5. Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
6. Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China
7. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Tuesday, March 16, 2010
8. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
9. Simceres Diosmectite API Passes EU-GMP Inspection
10. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
11. Simcere Pharmaceutical Group Files Annual Report on Form 20-F
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 2015 Axxess , an industry leader ... software vendor accredited by the American Nursing Credentialing Center ... health agencies select the right revenue cycle management (RCM) ... their business. Research by American Health Information ... expect a decrease in productivity of 54.4 - 69 ...
(Date:6/29/2015)... 29, 2015 The Parenteral Drug Association is ... Board of Professional Engineers and Land Surveyors ... to professional engineers for continuing professional competency (CPC) credits. ... value and quality of PDA,s professional education offerings," said ... and hands-on professional training at the Training and Research ...
(Date:6/29/2015)... EASTON, Mass. , June 29, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale ... preparation solutions to the worldwide life sciences industry, ... the Institute of Molecular Systems Biology, ETH Zurich, ... proteomic profiling and classification of prostate cancer tissue ...
Breaking Medicine Technology:Axxess Releases eGuide for Home Health Agencies, Revenue Cycle Management: What You Must Do Now - to Succeed! 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 2Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 3Better Classification of Prostate Cancer Tissue Biopsy Samples Enabled by Pressure BioSciences' PCT Platform 4
... Feb. 21, 2012 A collaboration between NineSigma and ... advance HIV vaccine research by identifying new approaches to ... provider of innovation services , NineSigma has connected ... and helped it identify two scientists who will receive ...
... #8116 -- Precyse, a leader in health information ... HIMSS 2012 Annual Conference and Exposition that the ... improvements in revenue cycle workflow, coding accuracy, and ... adopting Precyse,s integrated health information management (HIM) and ...
Cached Medicine Technology:IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 2IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 3IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines 4Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 2Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 3Growing List of Providers Accelerate Revenue Cycles, Improve Clinical Documentation Through True Computer-Assisted Coding with Natural Language Comprehension™ 4
(Date:6/30/2015)... CA (PRWEB) , ... June 30, 2015 , ... “It ... and founder of SunGrubbies.com. “We are particularly interested in getting the word out ... take years to surface. We are extremely pleased with our new video ...
(Date:6/29/2015)... ... June 30, 2015 , ... Aespala Medspa and Plastic Surgery is proud ... David Dreyfuss. , Dr. Dreyfuss received his medical degree from Emory University in ... by a Plastic Surgery Fellowship at the University of Chicago. He has taught and ...
(Date:6/29/2015)... (PRWEB) , ... June 30, 2015 , ... ... a set of revised Guidelines for Neuro Musculoskeletal Thermography and Sympathetic Skin Response ... original Guidelines that were first published in 2006, are intended to aid physicians ...
(Date:6/29/2015)... ... June 29, 2015 , ... Healthpointe, ... surgeon, Dr. John A. Mitamura, MD., PhD into their world-class multidisciplinary team of ... including Long Beach , Irwindale and La Tijera-Los Angeles. , Orthopedic ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... within the weekend edition of USA TODAY. This 12-page, glossy, full-color special section ... Today in highly targeted markets totaling approximately 450,000 copies, with an estimated readership ...
Breaking Medicine News(10 mins):Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 2Health News:SunGrubbies.com, a Leading Online Retailer of Sun Protection Products, Joins Effort to Promote Sun Safety 3Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 2Health News:Aespala Medspa and Plastic Surgery Welcomes New Plastic Surgeon to Oak Brook, IL Office 3Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 2Health News:American Academy of Thermology Publishes Revised 2015 Guidelines for Neuro-Musculoskeletal Thermography and Sympathetic Skin Response Studies 3Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 2Health News:Renowned Orthopedic and Spine Surgeon Joins Healthpointe in Long Beach 3Health News:Mediaplanet partners with USA TODAY and Kris Letang to raise awareness about the risk of heart attack and stroke 2
... 2011) -- The drug telaprevir (Incivek) provides a dramatic improvement ... C infection, says an international team of investigators led by ... Their study, published in today,s edition of the ... the agent for patient use by the U.S. Food and ...
... , WEDNESDAY, June 22 (HealthDay News) -- Walking, sex, ... most commonly used by pregnant women who want to ... women reported trying include exercise, acupuncture, masturbation, laxatives and ... conducted by Ohio State University researchers. Just over ...
... Doheny HealthDay Reporter , WEDNESDAY, June 23 ... periods of breast development may affect breast growth, the ... report contends. Some of these chemicals are found ... plastic water bottles, canned foods and laundry detergents, the ...
... standard for most patients with left main coronary artery disease, ... one that affects thousands. But a ... with this condition who underwent angioplasty with medication-coated stents, rather ... procedure than surgery, angioplasty is performed by snaking a tiny ...
... PROVIDENCE, R.I. [Brown University] Hepatocellular carcinoma is the ... 500,000 people worldwide, concentrated in sub-Saharan Africa and Southeast ... afflicted die within six months. A big obstacle ... early diagnosis. Current techniques, including ultrasound, CT and MRI ...
... Municipal Center for Disease Control and Prevention (Shanghai CDC) ... Fred Hutchinson Cancer Research Center, jointly will establish the ... laboratory" in China. The project is a result of ... a collaboration agreement., It marks the first such agreement ...
Cached Medicine News:Health News:NEJM study: New drug represents breakthrough in treatment of hepatitis C 2Health News:NEJM study: New drug represents breakthrough in treatment of hepatitis C 3Health News:Pregnant Women May Go to Great Lengths to Induce Labor 2Health News:Early Chemical Exposures May Affect Breast Health: Report 2Health News:Early Chemical Exposures May Affect Breast Health: Report 3Health News:Early Chemical Exposures May Affect Breast Health: Report 4Health News:Angioplasty with stents may be safe in long-term for low-risk heart patients 2Health News:Angioplasty with stents may be safe in long-term for low-risk heart patients 3Health News:Gold nanoparticles help earlier diagnosis of liver cancer 2Health News:Shanghai CDC and Hutchinson Center establish Shanghai Breast Health Resource Center 2Health News:Shanghai CDC and Hutchinson Center establish Shanghai Breast Health Resource Center 3
... Utilizing breakthrough electro-optical and rotary ... SUPRA is capable of obtaining ... pupils as narrow as 2.0mm. ... precise diagnostic results when dealing ...
Sterile perfluorocarbon for intraocular Application....
Sterile Silicone Oil for Intraocular Application....
Highly concentrated daily cleaner with Microclens beads for superior cleaning action....
Medicine Products: